Zhang et al. corroborated these findings, also reporting a markedly higher proportion of CD33+CD11b+HLA-DR− and CD33+CD11b−HLA-DR− T-MDSCs in the peripheral blood of BC patients compared to healthy donors [39]. Here, CD33 is linked to breast cancer.